indapamide has been researched along with Cognition Disorders in 7 studies
Indapamide: A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS.
indapamide : A sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The Hypertension in the Very Elderly Trial (HYVET) was a double blind placebo-controlled trial of antihypertensive treatment (indapamide SR 1." | 5.14 | Vascular risk factors and cognitive function among 3763 participants in the Hypertension in the Very Elderly Trial (HYVET): a cross-sectional analysis. ( Beckett, N; Bulpitt, C; Clarke, R; Fletcher, A; Forette, F; Peters, R; Poulter, R; Ritchie, C; Tuomilehto, J; Waldman, A; Walton, I, 2009) |
| "This is a secondary analysis of the Hypertension in the Very Elderly Trial (HYVET), a double blind, placebo controlled trial of indapamide, with or without perindopril, in people aged 80+ years at enrollment." | 5.14 | Modelling cognitive decline in the Hypertension in the Very Elderly Trial [HYVET] and proposed risk tables for population use. ( Beardmore, R; Beckett, N; Bulpitt, C; Mitnitski, A; Mt-Isa, S; Peña-Miller, R; Peters, R; Rockwood, K, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Püllen, R | 1 |
| Dovjak, P | 1 |
| Peters, R | 2 |
| Beckett, N | 2 |
| Forette, F | 1 |
| Tuomilehto, J | 1 |
| Ritchie, C | 1 |
| Walton, I | 1 |
| Waldman, A | 1 |
| Clarke, R | 1 |
| Poulter, R | 1 |
| Fletcher, A | 1 |
| Bulpitt, C | 2 |
| de Galan, BE | 1 |
| Zoungas, S | 1 |
| Chalmers, J | 2 |
| Anderson, C | 2 |
| Dufouil, C | 1 |
| Pillai, A | 1 |
| Cooper, M | 1 |
| Grobbee, DE | 1 |
| Hackett, M | 1 |
| Hamet, P | 1 |
| Heller, SR | 1 |
| Lisheng, L | 1 |
| MacMahon, S | 2 |
| Mancia, G | 1 |
| Neal, B | 2 |
| Pan, CY | 1 |
| Patel, A | 1 |
| Poulter, N | 1 |
| Travert, F | 1 |
| Woodward, M | 2 |
| Beardmore, R | 1 |
| Peña-Miller, R | 1 |
| Rockwood, K | 1 |
| Mitnitski, A | 1 |
| Mt-Isa, S | 1 |
| Mukhtar, O | 1 |
| Jackson, SH | 1 |
| Tzourio, C | 1 |
| Chapman, N | 1 |
| Widimský, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Hypertension in the Very Elderly Trial (HYVET)[NCT00122811] | Phase 4 | 4,000 participants (Anticipated) | Interventional | 2000-11-30 | Active, not recruiting | ||
| ADVANCE - Action in Diabetes and Vascular Disease: Preterax and Diamicron - MR Controlled Evaluation[NCT00145925] | Phase 3 | 11,140 participants (Actual) | Interventional | 2001-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for indapamide and Cognition Disorders
| Article | Year |
|---|---|
The Hypertension in the Very Elderly Trial - latest data.
Topics: Aged, 80 and over; Antihypertensive Agents; Cognition Disorders; Delayed-Action Preparations; Dement | 2013 |
3 trials available for indapamide and Cognition Disorders
| Article | Year |
|---|---|
Vascular risk factors and cognitive function among 3763 participants in the Hypertension in the Very Elderly Trial (HYVET): a cross-sectional analysis.
Topics: Aged, 80 and over; Antihypertensive Agents; Cardiovascular Diseases; Cognition Disorders; Comorbidit | 2009 |
Modelling cognitive decline in the Hypertension in the Very Elderly Trial [HYVET] and proposed risk tables for population use.
Topics: Aged, 80 and over; Antihypertensive Agents; Cognition Disorders; Double-Blind Method; Female; Humans | 2010 |
Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cerebrovasc | 2003 |
3 other studies available for indapamide and Cognition Disorders
| Article | Year |
|---|---|
[Not Available].
Topics: Activities of Daily Living; Antihypertensive Agents; Cognition Disorders; Female; Humans; Hypertensi | 2013 |
Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.
Topics: Aged; Antihypertensive Agents; Cognition; Cognition Disorders; Diabetes Mellitus, Type 2; Diabetic A | 2009 |
[Management of dementia and cognitive functions in patients after cerebrovascular stroke: new results from the PROGRESS study].
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Cognition Disorders; Dementia; Humans; Hypertensio | 2003 |